Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Scientific Reports
|
July 7, 2019
Engineering multi-layered tissue constructs using acoustic levitation
Angela Tait, Peter Glynne-Jones, Alison R Hill, et al.
The Journal of Clinical Investigation
|
January 17, 2023
Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge
Annieck M Diks, Hans de Graaf, Cristina Teodosio, et al.
NPJ Vaccines
|
April 18, 2026
BPZE1 vaccination induces IL-17<sup>+</sup> and IL-22<sup>+</sup> CD4<sup>+</sup> T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation
Alison R Hill, Diane F Gbesemete, Tyween Coutinho, et al.
Tissue Barriers
|
September 2, 2016
IL-1α mediates cellular cross-talk in the airway epithelial mesenchymal trophic unit
Alison R Hill, Jessica E Donaldson, Cornelia Blume, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 29, 2019
Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization
Hans de Graaf, Muktar Ibrahim, Alison R Hill, et al.
The Lancet. Microbe
|
December 3, 2022
Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial
Adam P Dale, Anastasia A Theodosiou, Diane F Gbesemete, et al.
The Lancet. Microbe
|
December 4, 2025
Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis
Diane Gbesemete, Maheshi N Ramasamy, Muktar Ibrahim, et al.
The Lancet. Microbe
|
March 26, 2026
Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study
Hans de Graaf, Diane F Gbesemete, Alison R Hill, et al.
Science Translational Medicine
|
July 8, 2021
A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage
Jay R Laver, Diane Gbesemete, Adam P Dale, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Scientific Reports
|
July 7, 2019
Engineering multi-layered tissue constructs using acoustic levitation
Angela Tait, Peter Glynne-Jones, Alison R Hill, et al.
The Journal of Clinical Investigation
|
January 17, 2023
Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge
Annieck M Diks, Hans de Graaf, Cristina Teodosio, et al.
NPJ Vaccines
|
April 18, 2026
BPZE1 vaccination induces IL-17<sup>+</sup> and IL-22<sup>+</sup> CD4<sup>+</sup> T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation
Alison R Hill, Diane F Gbesemete, Tyween Coutinho, et al.
Tissue Barriers
|
September 2, 2016
IL-1α mediates cellular cross-talk in the airway epithelial mesenchymal trophic unit
Alison R Hill, Jessica E Donaldson, Cornelia Blume, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 29, 2019
Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization
Hans de Graaf, Muktar Ibrahim, Alison R Hill, et al.
The Lancet. Microbe
|
December 3, 2022
Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial
Adam P Dale, Anastasia A Theodosiou, Diane F Gbesemete, et al.
The Lancet. Microbe
|
December 4, 2025
Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis
Diane Gbesemete, Maheshi N Ramasamy, Muktar Ibrahim, et al.
The Lancet. Microbe
|
March 26, 2026
Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study
Hans de Graaf, Diane F Gbesemete, Alison R Hill, et al.
Science Translational Medicine
|
July 8, 2021
A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage
Jay R Laver, Diane Gbesemete, Adam P Dale, et al.
Page
of 1